Cytokinetics | Passivo Circulante



Current Liabilities Alterar Data
Acadia Pharmaceuticals USD 394.87M 50.92M 2024-12
Amgen USD 23.1B 2.79B 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Bristol-Myers Squibb USD 24.07B 296M 2025-03
Cytokinetics USD 179.67M 69.86M 2024-12
Eisai JPY 381.62B 54.78B 2024-12
Eli Lilly USD 28.38B 3.7B 2024-12
Exelixis USD 403.77M 9.42M 2025-01
Geron USD 88.3M 49.64M 2024-12
Halozyme Therapeutics USD 139.1M 30.28M 2024-12
Ionis Pharmaceuticals USD 309.32M 4.75M 2024-12
Ligand Pharmaceuticals USD 37.11M 12.34M 2024-12
Merck USD 28.42B 1.17B 2024-12
Novartis USD 28.69B 560M 2024-12
Pfizer USD 43B 216M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Sanofi 32.22B 3.06B 2025-03



Cytokinetics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.